A novel tool to analyze MRI recurrence patterns in glioblastoma

Neuro-Oncology

Volumn 10, Issue 6, 2008, Pages 1019-1024

  Wick, Wolfgang ^a,b   Stupp, Roger ^c   Beule, Anna Carina ^a   Bromberg, Jacoline ^d   Wick, Antje ^a   Ernemann, Ulrike ^e   Platten, Michael ^a,b   Marosi, Christine ^f   Mason, Warren P ^g   Van Den Bent, Martin ^d   Weller, Michael ^a   Rorden, Chris ^h   Karnath, Hans Otto ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g PRINCESS MARGARET HOSPITAL   (Canada)

^h UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Brain tumor; Invasiveness; MRIcro; Relapse pattern; Temozolomide

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE; ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE;

ARTICLE; BRAIN MAPPING; CANADA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CELL INVASION; CLINICAL EXAMINATION; CLINICAL STUDY; COHORT ANALYSIS; COMPUTER PROGRAM; GLIOBLASTOMA; GLIOMA CELL; HUMAN; MAJOR CLINICAL STUDY; METHYLATION; MORBIDITY; NATIONAL HEALTH ORGANIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; TUMOR LOCALIZATION; BRAIN TUMOR; COMPUTER ASSISTED DIAGNOSIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOGRAPHY; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; GLIOBLASTOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 60549083123     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1215/15228517-2008-058     Document Type: Article

References (14)

1. Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9:157-173.
2. Macdonald DR, Cascino TL, Schold SC, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8:1277-1280.
3. Giese A, Kucinski T, Knopp U, et al. Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma. J Neurooncol. 2004;66:351-360.
4. Weber MA, Zoubaa S, Schlieter M, et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology. 2006; 66:1899-1906.
5. Khong PL, Leung LH, Fung AS, et al. White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. J Clin Oncol. 2006;24:884-890.
6. Stupp R, Mason WP, van den Bent MJ, et al., on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor and Radiotherapy Groups and National Cancer Institute of Canada Clinical Trials Group (NCIC CTG). Radiotherapy plus concomitant and adjuvant temozolomide for patients with newly diagnosed glioblastoma. N Engl J Med. 2005;352:987-996.
7. Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res. 2001;61:2744-2750.
8. Wick W, Wick A, Schulz JB, Dichgans J, Rodemann HP, Weller M. Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase-3-activity and cleavage of focal adhesion kinase. Cancer Res. 2002;62:1915-1919.
9. Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol. 2000;12:191-200.
10. Rorden C, Karnath H-O, Bonilha L. Improving lesion-symptom mapping. J Cogn Neurosci 2007;19:1081-1088.
11. Rorden C, Karnath HO. Using human brain lesions to infer function: a relic from a past era in the fMRI age? Nat Rev Neurosci. 2004;5:813-819.
12. Massey V, Wallner K. Patterns of second recurrence of malignant astrocytomas. Int J Radiat Oncol Biol Phys. 1990;18:395-398.
13. Hess C, Schaaf, Kortmann R, Schabet M, Bamberg M. Malignant gliomas: patterns of failure following individually tailored limited-volume irradiation. Radiother Oncol. 1994;30:146-149.
14. Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and response to temozolomide in glioblastoma. N Engl J Med. 2005;352:997-1003.